Target intelligence / Profile preview

Ribosomal protein L32 pseudogene 25 (RPL32P25)

Target
RPL32P25
Molecular classification
Other (Pseudogene)
01

Overview

Ribosomal protein L32 pseudogene 25 is a non-coding pseudogene of RPL32, found in the human genome[4][7]. Unlike its parent gene, which encodes a component of the 60S ribosomal subunit and is anchored in protein synthesis, RPL32P25 does not encode any functional protein, nor is there evidence for its transcription or translation[4][7][8]. Pseudogenes such as RPL32P25 generally arise due to gene duplication or retrotransposition, resulting in a genomic sequence that resembles the original gene yet is rendered nonfunctional by disruptive mutations, lack of regulatory elements, or absence of an open reading frame[6]. While some ribosomal protein pseudogenes have been reported to regulate gene expression in cancer or other cellular processes, there is no specific evidence or literature supporting any functional role, disease association, or drug interaction for RPL32P25 itself[2][4][8]. Therefore, RPL32P25 should not be considered a bona fide therapeutic target nor a candidate for drug development.

Other names
RPL32_16_1167RPL32P25
02

Biological functions

Other — RPL32P25 has no direct protein-coding or ribosomal function. There is no published data linking specific biological function to RPL32P25 (distinct from other RPL32 pseudogenes which may have regulatory roles[2]).
03

Disease associations

Other — No direct association with disease is reported for RPL32P25. Some ribosomal protein pseudogenes (for example RPL32P3) may be involved in cancer or cell permeability, but not specifically RPL32P25[2].

Beyond the preview

Go deeper on Ribosomal protein L32 pseudogene 25 (RPL32P25).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L32 pseudogene 25 (RPL32P25).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call